{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:12:53Z","timestamp":1778587973300,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jconrel.2013.04.019","type":"journal-article","created":{"date-parts":[[2013,5,4]],"date-time":"2013-05-04T14:54:37Z","timestamp":1367679277000},"page":"153-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular application"],"prefix":"10.1016","volume":"170","author":[{"given":"Marta","family":"Rodriguez-Aller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davy","family":"Guillarme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El Sanharawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Behar-Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Veuthey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Gurny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2013.04.019_bb0005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.2042-7158.2011.01279.x","article-title":"Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes","volume":"63","author":"Loftsson","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejps.2005.05.003","article-title":"A water-soluble prodrug of cyclosporine A for ocular application: a stability study","volume":"26","author":"Lallemand","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0015","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09273948.2010.498657","article-title":"Clinical review: topical ophthalmic use of cyclosporin A","volume":"18","author":"Utine","year":"2010","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","article-title":"Topical ophthalmic cyclosporine: pharmacology and clinical uses","volume":"54","author":"Donnenfeld","year":"2009","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/10408368709105886","article-title":"Cyclosporine: structure, pharmacokinetics, and therapeutic drug monitoring","volume":"25","author":"Vine","year":"1987","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0030","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/0002-9343(84)90356-5","article-title":"Side effects of systemic cyclosporine in patients not undergoing transplantation","volume":"77","author":"Palestine","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/02652049709033830","article-title":"Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study","volume":"14","author":"Le Bourlais","year":"1997","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00003226-198906000-00002","article-title":"Ultrastructural and immunohistochemical study on the effect of topical cyclosporin A in the rabbit eye","volume":"8","author":"Versura","year":"1989","journal-title":"Cornea"},{"key":"10.1016\/j.jconrel.2013.04.019_bb0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00003226-199403000-00006","article-title":"Influence of topically applied cyclosporine A in olive oil on corneal epithelium permeability","volume":"13","author":"Benitez del Castillo","year":"1994","journal-title":"Cornea"},{"key":"10.1016\/j.jconrel.2013.04.019_bb0050","first-page":"213","article-title":"Cyclosporin A eyedrops in the prevention of high-risk corneal graft rejection. II. Postoperative clinical results","volume":"10","author":"Goichot-Bonnat","year":"1987","journal-title":"J. Fr. Ophtalmol."},{"issue":"Pt. 4","key":"10.1016\/j.jconrel.2013.04.019_bb0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/eye.1997.126","article-title":"A comparative approach to topical cyclosporine therapy","volume":"11","author":"Williams","year":"1997","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2013.04.019_bb0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1023\/A:1013671819604","article-title":"Cyclosporine A formulation affects its ocular distribution in rabbits","volume":"19","author":"Kuwano","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0065","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bjo.73.8.600","article-title":"Penetration of 2% cyclosporin eyedrops into human aqueous humour","volume":"73","author":"Diaz-Llopis","year":"1989","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0070","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3109\/02713689209000737","article-title":"Influence of vehicle and anterior chamber protein concentration on cyclosporine penetration through the isolated rabbit cornea","volume":"11","author":"Cheeks","year":"1992","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0075","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1399-3011.2005.00234.x","article-title":"Water-soluble prodrugs of cyclosporine A with tailored conversion rates","volume":"65","author":"Hamel","year":"2005","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejpb.2004.07.002","article-title":"Conversion of cyclosporine A prodrugs in human tears vs rabbits tears","volume":"59","author":"Lallemand","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijpharm.2004.12.015","article-title":"A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics","volume":"295","author":"Lallemand","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ejpb.2007.03.011","article-title":"Biological conversion of a water-soluble prodrug of cyclosporine A","volume":"67","author":"Lallemand","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0095","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejpb.2011.11.017","article-title":"In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease","volume":"80","author":"Rodriguez-Aller","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0100","series-title":"Clarke's Isolation and Identification of Drugs","author":"Clarke","year":"1986"},{"key":"10.1016\/j.jconrel.2013.04.019_bb0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0181-5512(06)73780-9","article-title":"Cytotoxicity evaluation of different eyes drops with cyclosporine oral solution (Sandimmun)","volume":"29","author":"Nourry","year":"2006","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0378-5173(83)90041-8","article-title":"The role of esterase-activity in the ocular disposition of dipivalyl epinephrine in rabbits","volume":"17","author":"Redell","year":"1983","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/bdd.2510030402","article-title":"Esterase distribution in the rabbit cornea and its implications in ocular drug bioavailability","volume":"3","author":"Lee","year":"1982","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0120","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/jps.2600721108","article-title":"Corneal penetration behavior of beta-blocking agents I: Physiochemical factors","volume":"72","author":"Schoenwald","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00010-5","article-title":"Ocular absorption following topical delivery","volume":"16","author":"Jarvinen","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0130","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0042-6989(72)90005-3","article-title":"A revision of the rat schematic eye","volume":"12","author":"Massof","year":"1972","journal-title":"Vision Res."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/rtph.1998.1243","article-title":"Binding of drugs to eye melanin is not predictive of ocular toxicity","volume":"28","author":"Leblanc","year":"1998","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-409X(01)00193-4","article-title":"Transscleral drug delivery for posterior segment disease","volume":"52","author":"Geroski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0150","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0155","first-page":"627","article-title":"Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera","volume":"38","author":"Hamalainen","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/02713688809031801","article-title":"Comparison of conjunctival and corneal surface areas in rabbit and human","volume":"7","author":"Watsky","year":"1988","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0165","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0170","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000265516","article-title":"Hydrolysis of prednisolone succinate by esterase in rabbit ocular tissue","volume":"19","author":"Tsuji","year":"1987","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0175","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/02713688209020024","article-title":"Subcellular distribution of esterases in the bovine eye","volume":"2","author":"Lee","year":"1982","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0180","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3109\/02713688509003358","article-title":"Ocular esterase composition in albino and pigmented rabbits: possible implications in ocular prodrug design and evaluation","volume":"4","author":"Lee","year":"1985","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0185","first-page":"570","article-title":"Surface features of the conjunctiva and cornea","volume":"24","author":"Nichols","year":"1983","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0190","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/archopht.1990.01070060132063","article-title":"Ocular penetration of cyclosporine A in the rat eye","volume":"108","author":"BenEzra","year":"1990","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0195","first-page":"1362","article-title":"Ocular penetration of cyclosporin A. The rabbit eye","volume":"31","author":"BenEzra","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0200","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/bjo.74.6.350","article-title":"Ocular penetration of cyclosporin A. III: the human eye","volume":"74","author":"BenEzra","year":"1990","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1076\/ceyr.18.2.91.5381","article-title":"Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs","volume":"18","author":"Acheampong","year":"1999","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2008.08.004","article-title":"Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results","volume":"365","author":"Gan","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0215","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2010.10.008","article-title":"Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: improving in vivo ocular distribution","volume":"402","author":"Shen","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0220","first-page":"519","article-title":"Pharmacokinetic of topical cyclosporin A in the rabbit eye","volume":"27","author":"Wiederholt","year":"1986","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0225","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.transproceed.2012.09.081","article-title":"Correlations between cyclosporine concentrations at 2hours post-dose and trough levels with functional outcomes in de novo lung transplant recipients","volume":"44","author":"Maziers","year":"2012","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0230","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ndt\/6.7.512","article-title":"Circadian rhythm of T-lymphocyte subsets, cortisol and cyclosporin in kidney-transplanted subjects","volume":"6","author":"Cugini","year":"1991","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0235","first-page":"2242","article-title":"Cyclosporine-a (Csa) \u2014 models for the mechanism of action","volume":"15","author":"Lafferty","year":"1983","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.jconrel.2013.04.019_bb0240","first-page":"650","article-title":"Intraocular penetration of topically applied cyclosporine","volume":"20","author":"Kaswan","year":"1988","journal-title":"Transplant. Proc."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913002381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913002381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T06:20:14Z","timestamp":1539670814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365913002381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0168365913002381"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.04.019","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular application","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}